2-32947681-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_206943.4(LTBP1):c.357C>A(p.His119Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000506 in 1,494,734 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_206943.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LTBP1 | NM_206943.4 | c.357C>A | p.His119Gln | missense_variant | 1/34 | ENST00000404816.7 | NP_996826.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LTBP1 | ENST00000404816.7 | c.357C>A | p.His119Gln | missense_variant | 1/34 | 5 | NM_206943.4 | ENSP00000386043 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000455 AC: 69AN: 151736Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000399 AC: 46AN: 115158Hom.: 0 AF XY: 0.000304 AC XY: 20AN XY: 65782
GnomAD4 exome AF: 0.000512 AC: 687AN: 1342890Hom.: 0 Cov.: 33 AF XY: 0.000500 AC XY: 332AN XY: 664298
GnomAD4 genome AF: 0.000454 AC: 69AN: 151844Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 27, 2023 | The c.357C>A (p.H119Q) alteration is located in exon 1 (coding exon 1) of the LTBP1 gene. This alteration results from a C to A substitution at nucleotide position 357, causing the histidine (H) at amino acid position 119 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at